INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2012

A review discusses clinical decisions for radioactive iodine therapy, including pretherapy low-iodine diet in thyroid disease management.

This review summarizes management decisions made by endocrinologists during radioactive iodine (RAI) therapy for hyperthyroidism and differentiated thyroid cancer. Pretherapy decisions covered include the use of antithyroid medications and a low-iodine diet based on supportive literature. It also highlights guideline changes and recent randomized controlled trials modifying how RAI is used for remnant ablation and adjuvant therapy to help limit radiation exposure.

Study type
Narrative review
Who was studied
Patients with hyperthyroidism and differentiated thyroid cancer
What was measured
Management decisions and clinical practice of radioactive iodine (RAI) therapy

THE PAPER

Radioactive iodine therapy.

Lee SL. Curr Opin Endocrinol Diabetes Obes, 2012.

PubMed 22914564 ↗DOI 10.1097/med.0b013e328357fa0c ↗

CancerOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.